In a field trial with more than 700 cows and heifers, two doses of J-VAC treatment reduced the incidence of clinical coliform mastitis cases by 81 percent.*
Coliform Mastitis Vaccine
J-Vac® is a broad-spectrum bacterin-toxoid that aids in the prevention of mastitis caused by Escherichia coli and the effects of endotoxemia caused by E. coli and Salmonella Typhimurium.
It is approved for a whole-herd protocol and can be used for lactating cows, heifers or dry cows.
J-Vac® treatment is the only vaccine of its kind approved for usage in the whole herd.
In just two doses, J-VAC treatment protects against coliform mastitis caused by E. coli and endotoxemia caused by E. coli and Salmonella Typhimurium.
The unique TANDEM™ adjuvant in J-VAC treatment keeps antigens in suspension, releasing them over time, and stimulating enhanced immunity.
J-VAC treatment is easy to administer with a whole herd, two-dose protocol, and can reduce the incidence of clinical coliform mastitis cases by 81%.*
Labeled for flexible administration, with intramuscular and subcutaneous injection-route options.
*Data on file at Boehringer Ingelheim
As an aid in the prevention of coliform mastitis, inject 2 mL (one dose) intramuscularly or subcutaneously at seven months of gestation or at dry-off. Revaccinate at one to three weeks before calving. Approved for whole-herd use.
As an aid in the prevention of the effects of endotoxemia, whole-herd vaccination may be done at any time. Vaccinate with 2-mL (one dose) followed by a second 2 mL dose two to four weeks later.
Annual revaccination required.
Calves vaccinated under 6 months of age should be revaccinated after reaching 6 months of age.
Additional Administration Information:
Product Inserts & Labels
Always read and follow label directions.
Proven Efficacy. Two Doses.
How to Administer J-VAC Treatment
J-VAC® is a registered trademark and the J-VAC logo and TANDEM™ are trademarks of Boehringer Ingelheim Animal Health USA Inc. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-BOV-0394-2021